|Daily Range||$0.00 - $0.00|
|52-Week Range||$13.13 - $50.98|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,292,887|
|Current FY EPS||-$0.36|
INTREXON CORP (XON) Description
INTREXON CORP Website: http://www.dna.com/
News & Commentary
A new apple product could generate over $1 billion at its peak, but it probably isn't on your investing radar.
Omnicare (OCR) Catches Eye: Stock Rises 5.2% - Tale of the Tape
The Shell/BG Group merger may signal the beginning of a flurry of M&A activity in the oil and gas sector as commodity prices put smaller companies under pressure.
Cancer deal this, cancer deal that. Intrexon investors should pay attention to the growth potential beyond healthcare applications.
After decades of false starts, new immunotherapies are achieving long-lasting remissions in patients with extremely deadly cancers. Some doctors are even daring to use the word "cure."